Please select one: * I am in active clinical practice I am retired I am a student Other Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. * Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable 54321NA The skills learned in this CME course enhanced my professional competence. The skills learned in this CME course enhanced my professional competence. - 5 The skills learned in this CME course enhanced my professional competence. - 4 The skills learned in this CME course enhanced my professional competence. - 3 The skills learned in this CME course enhanced my professional competence. - 2 The skills learned in this CME course enhanced my professional competence. - 1 The skills learned in this CME course enhanced my professional competence. - NA The skills learned in this CME course will be applied in the treatment of my patients The skills learned in this CME course will be applied in the treatment of my patients - 5 The skills learned in this CME course will be applied in the treatment of my patients - 4 The skills learned in this CME course will be applied in the treatment of my patients - 3 The skills learned in this CME course will be applied in the treatment of my patients - 2 The skills learned in this CME course will be applied in the treatment of my patients - 1 The skills learned in this CME course will be applied in the treatment of my patients - NA How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? * Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied 54321 Discuss the role of CDK4/6 inhibitors for the treatment of advanced breast cancer and early breast cancer Discuss the role of CDK4/6 inhibitors for the treatment of advanced breast cancer and early breast cancer - 5 Discuss the role of CDK4/6 inhibitors for the treatment of advanced breast cancer and early breast cancer - 4 Discuss the role of CDK4/6 inhibitors for the treatment of advanced breast cancer and early breast cancer - 3 Discuss the role of CDK4/6 inhibitors for the treatment of advanced breast cancer and early breast cancer - 2 Discuss the role of CDK4/6 inhibitors for the treatment of advanced breast cancer and early breast cancer - 1 Explain the most common CDK4/6 inhibitors and discuss their clinical profiles. Explain the most common CDK4/6 inhibitors and discuss their clinical profiles. - 5 Explain the most common CDK4/6 inhibitors and discuss their clinical profiles. - 4 Explain the most common CDK4/6 inhibitors and discuss their clinical profiles. - 3 Explain the most common CDK4/6 inhibitors and discuss their clinical profiles. - 2 Explain the most common CDK4/6 inhibitors and discuss their clinical profiles. - 1 Outline strategies for monitoring side effects. Outline strategies for monitoring side effects. - 5 Outline strategies for monitoring side effects. - 4 Outline strategies for monitoring side effects. - 3 Outline strategies for monitoring side effects. - 2 Outline strategies for monitoring side effects. - 1 Was this course fair, balanced and without commercial bias? * Yes No If you checked "No,” please explain why: * What, if any, new skills/strategies will you apply in your clinical practice? * If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so? * Please provide any additional comments or suggestions. How did you hear about this course? * CME website Hospital-based Digital signage Email Google search Facebook LinkedIn Miami Medicine Journal CE Finder (CE Broker) CME Passport (ACCME) Other... How did you hear about this course? Other... Please select one: * M.D., D.O. Ph.D/Psy.D APRN/PA-C R.N. Dietitian Social Worker/MHC/MFT Pharmacist Respiratory Other... Please select one: Other... Name Leave this field blank
